• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阿尔茨海默病中P物质代谢和神经肽酶的改变。

Alterations of substance P metabolism and neuropeptidases in Alzheimer's disease.

作者信息

Waters S M, David T P

机构信息

Department of Pharmacology, University of Arizona College of Medicine, Tucson, USA.

出版信息

J Gerontol A Biol Sci Med Sci. 1995 Sep;50(5):B315-9. doi: 10.1093/gerona/50a.5.b315.

DOI:10.1093/gerona/50a.5.b315
PMID:7545530
Abstract

The levels of specific neuropeptides and the activity of neuropeptidases known to degrade neuropeptides have been shown to be altered in senile dementia of the Alzheimer's type (SDAT) postmortem brain. We examined the metabolism of exogenous substance P, a neuropeptide with a putative role in SDAT pathology, in human postmortem temporal cortex, hippocampus, and caudate membrane homogenates from SDAT and sex- and age-matched control brain. The activity of two neuropeptidases known to metabolize substance P, neutral endopeptidase E.C.3.4.24.11 and metalloendopeptidase E.C.3.4.24.15, was also determined in the same postmortem, human tissue samples. The metabolic half-life of substance P was significantly increased in SDAT, postmortem, temporal cortex. The increased half-life of substance P was correlated with a decreased activity of the metabolic enzyme metalloendopeptidase 24.15 in temporal cortex. Substance P metabolism was not significantly altered in hippocampus or caudate tissues from SDAT brain compared to controls. The alteration of neuropeptidases demonstrated in this study and as shown by altered substance P metabolism may have a significant effect on the level of several biologically important neuropeptides in SDAT brain.

摘要

在阿尔茨海默病型老年痴呆症(SDAT)的尸检大脑中,特定神经肽的水平以及已知可降解神经肽的神经肽酶的活性已被证明发生了改变。我们检测了外源性P物质(一种在SDAT病理学中可能起作用的神经肽)在来自SDAT以及性别和年龄匹配的对照大脑的人类尸检颞叶皮质、海马体和尾状核膜匀浆中的代谢情况。在相同的尸检人类组织样本中,还测定了两种已知可代谢P物质的神经肽酶的活性,即中性内肽酶E.C.3.4.24.11和金属内肽酶E.C.3.4.24.15。在SDAT尸检颞叶皮质中,P物质的代谢半衰期显著延长。P物质半衰期的延长与颞叶皮质中代谢酶金属内肽酶24.15的活性降低相关。与对照组相比,SDAT大脑海马体或尾状核组织中的P物质代谢没有显著改变。本研究中所证实的神经肽酶的改变以及P物质代谢的改变,可能会对SDAT大脑中几种具有生物学重要性的神经肽水平产生显著影响。

相似文献

1
Alterations of substance P metabolism and neuropeptidases in Alzheimer's disease.阿尔茨海默病中P物质代谢和神经肽酶的改变。
J Gerontol A Biol Sci Med Sci. 1995 Sep;50(5):B315-9. doi: 10.1093/gerona/50a.5.b315.
2
Metabolic half-life of somatostatin and peptidase activities are altered in Alzheimer's disease.阿尔茨海默病中生长抑素的代谢半衰期和肽酶活性发生改变。
J Gerontol. 1992 Jan;47(1):B18-25. doi: 10.1093/geronj/47.1.b18.
3
Alterations of peptide metabolism and neuropeptidase activity in senile dementia of the Alzheimer's type.阿尔茨海默型老年痴呆症中肽代谢和神经肽酶活性的改变。
Ann N Y Acad Sci. 1997 Apr 24;814:30-9. doi: 10.1111/j.1749-6632.1997.tb46142.x.
4
Brain insulin and insulin receptors in aging and sporadic Alzheimer's disease.衰老与散发性阿尔茨海默病中的脑胰岛素及胰岛素受体
J Neural Transm (Vienna). 1998;105(4-5):423-38. doi: 10.1007/s007020050068.
5
VIP-sensitive adenylate cyclase, guanylate cyclase, muscarinic receptors, choline acetyltransferase and acetylcholinesterase, in brain tissue afflicted by Alzheimer's disease/senile dementia of the Alzheimer type.在受阿尔茨海默病/阿尔茨海默型老年痴呆症影响的脑组织中的血管活性肠肽敏感腺苷酸环化酶、鸟苷酸环化酶、毒蕈碱受体、胆碱乙酰转移酶和乙酰胆碱酯酶。
Neurobiol Aging. 1988 Mar-Apr;9(2):153-62. doi: 10.1016/s0197-4580(88)80045-9.
6
Influence of region-specific alterations of neuropeptidase content on the catabolic fates of neuropeptides in Alzheimer's disease.神经肽酶含量的区域特异性改变对阿尔茨海默病中神经肽分解代谢命运的影响。
J Neurochem. 1994 Feb;62(2):645-55. doi: 10.1046/j.1471-4159.1994.62020645.x.
7
Haloperidol and apomorphine differentially affect neuropeptidase activity.
J Pharmacol Exp Ther. 1996 Apr;277(1):113-20.
8
Reduced amounts of immunoreactive somatostatin in the temporal cortex in senile dementia of Alzheimer type.在阿尔茨海默型老年痴呆症患者的颞叶皮质中,免疫反应性生长抑素含量减少。
Neurosci Lett. 1980 Dec;20(3):373-7. doi: 10.1016/0304-3940(80)90177-9.
9
Brain histamine in Alzheimer's disease.阿尔茨海默病中的脑组胺。
Methods Find Exp Clin Pharmacol. 1989 May;11(5):353-60.
10
125I-galanin binding sites in Alzheimer's disease: increases in hippocampal subfields and a decrease in the caudate nucleus.阿尔茨海默病中125I-甘丙肽结合位点:海马亚区增加,尾状核减少。
J Neurochem. 1997 Mar;68(3):1106-13. doi: 10.1046/j.1471-4159.1997.68031106.x.

引用本文的文献

1
The Double-Edged Effects of Substance P in the Pathology of Alzheimer's Disease.P物质在阿尔茨海默病病理学中的双刃剑效应
Aging Dis. 2024 Oct 15;16(5):2870-2889. doi: 10.14336/AD.2024.0960.
2
Neprilysin inhibitors and risk of Alzheimer's disease: A future perspective.奈普利酶抑制剂与阿尔茨海默病风险:未来展望。
J Cell Mol Med. 2024 Jan;28(2):e17993. doi: 10.1111/jcmm.17993. Epub 2023 Oct 17.
3
Neuropeptides Exert Neuroprotective Effects in Alzheimer's Disease.神经肽在阿尔茨海默病中发挥神经保护作用。
Front Mol Neurosci. 2019 Jan 11;11:493. doi: 10.3389/fnmol.2018.00493. eCollection 2018.
4
Identification and characterization of Aβ peptide interactors in Alzheimer's disease by structural approaches.通过结构方法鉴定和分析阿尔茨海默病中 Aβ 肽的相互作用因子。
Front Aging Neurosci. 2014 Oct 9;6:265. doi: 10.3389/fnagi.2014.00265. eCollection 2014.